Niagen Bioscience Inc. (NAGE)
NASDAQ (CM) NASDAQ (CM) Primary 
Niagen Bioscience, Inc. (NAGE) Q1 202 Earnings Call Transcript
Niagen Bioscience, Inc. Q1 2025 - Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Wesley Yu - VP of Finance Rob Fried - CEO Ozan Pamir - CFO Andrew Shao - SVP, Scientific & Regulatory Affairs Conference Call Participants Ram Selvaraju - H. C. Wainwright Mitch Pinheiro - Sturdivant & Company Sean McGowan - ROTH Capital Partners Matt Dain - Tieton Capital Management Susan Anderson - Canaccord Genuity JP Mark - Farmhouse Equity Research Operator Ladies and gentlemen, thank you for standing by, and welcome to Niagen Biosciences Inc. First Quarter of 2025 Earnings Conference Call.
Niagen Bioscience (NAGE) Q1 Earnings and Revenues Beat Estimates
Niagen Bioscience (NAGE) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to loss of $0.01 per share a year ago.
